LumiraDx Receives CE Mark for Two Multiplex Molecular Tests
LumiraDx achieved CE Mark for two new molecular tests, the Dual-Target SARS-CoV-2 STAR Complete and SARS-CoV-2 & Flu A/B RNA STAR Complete.
Read MorePosted by Andy Lundin | Jun 9, 2022 | Covid 19, Molecular Diagnostics |
LumiraDx achieved CE Mark for two new molecular tests, the Dual-Target SARS-CoV-2 STAR Complete and SARS-CoV-2 & Flu A/B RNA STAR Complete.
Read MorePosted by Andy Lundin | Jun 9, 2022 | Covid 19 |
Premier Medical Laboratory Services has identified the first BA.4 variant cases reported in the state of Florida.
Read MorePosted by Chris Wolski | Jun 9, 2022 | Emerging & Zoonotic Diseases |
The monkeypox molecular test will be available for BD MAX users and may help advance understanding of the global spread of the disease.
Read MorePosted by Andy Lundin | Jun 8, 2022 | Disease States |
Researchers examined how variants of uncertain significance can be introduced by underrepresentation of certain ancestry groups.
Read MorePosted by Chris Wolski | Jun 6, 2022 | Covid 19, White Papers |
COVID-19 is entering its endemic phase, due to a combination of scientific reality with falling infection numbers in first-world countries
Read More